Stay updated on PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page.
Latest updates to the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedOtsuka Pharmaceutical Development & Commercialization, Inc. has been added, while Sumitomo Pharma America, Inc. has been removed.SummaryDifference3%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check43 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check50 days agoChange DetectedResults have been posted on November 25, 2024, replacing the previous status of results submitted on June 28, 2023.SummaryDifference1%
- Check57 days agoChange DetectedThe website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.SummaryDifference13%
Stay in the know with updates to PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page.